Anatara Lifesciences (ASX:ANR) Announces Phase II GaRP-IBS Trial Results
Anatara Lifesciences (ASX:ANR) reports Phase II GaRP-IBS trial results, highlighting safety and significant symptom relief trends.
Anatara Lifesciences (ASX:ANR) reports Phase II GaRP-IBS trial results, highlighting safety and significant symptom relief trends.
Streamplay Studio (ASX:SP8) partners with Mobibox to launch Playstream cloud gaming service exclusively for Sri Lanka’s largest mobile operator.
Simble Solutions Limited (ASX:SIS) reports significant 2024 operational achievements and strategic partnerships, driving growth and expansion.
Hastings Technology Metals (ASX:HAS) forms a 60:40 joint venture with Wyloo for the Yangibana Project, advancing development and reducing costs.
Tempest Minerals Limited (ASX:TEM) reports excellent initial metallurgical results for the Remorse Deposit at Yalgoo Project.
Chimeric Therapeutics (ASX:CHM) reports that two of three patients achieved complete response in its ADVENT-AML Phase 1B clinical trial.
Ava Risk Group (ASX:AVA) secures a A$1.1 million contract with Honeywell to deploy its sensing technology in Abu Dhabi’s oil and gas field.
Tamboran Resources Corporation (ASX:TBN) announces 3Q FY25 results, highlighting successful well completions and financial milestones.
Mesoblast (ASX:MSB) secures 7-year FDA orphan-drug exclusivity for Ryoncilâ„¢ in treating pediatric SR-aGvHD, strengthening its IP protection.
Errawarra Resources (ASX:ERW) reports multiple high-grade silver results up to 920g/t, highlighting significant exploration potential at Elizabeth Hill.